Willowcroft Pharm

New Products and Services posts tagged "Willowcroft Pharm"

LAMINITIS DRUG TREATMENT SAVING HORSE'S LIVES

  • 18 Jun 2014 9:18 AM

Willowcroft Pharm, Inc., developer of the successful laminitis drug treatment, Laminil, announced today that it is offering up to 60,000,000 shares of preferred stock at a price of $0.08333 per share. ... Read More

Recent Posts

News

Disclaimer: The statements/claims expressed herein are solely the views or opinions of the person(s)/company submitting the information to Blood-Horse Publications and do not necessarily reflect the views or opinions of Blood-Horse Publications, nor have these statements/products/services been reviewed/evaluated by Blood-Horse Publications prior to publication. Any claims/statements made herein should not be attributed to Blood-Horse Publications.

More Blogs

Archives